Paper Details

  1. Home
  2. Paper Details

Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris in a preadolescent population.

Author: BhattVarsha, EichenfieldLawrence F, GueninEric, HarrisSusan, SugarmanJeffrey L

Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Acne is a common problem for children and teenagers. Tretinoin has been shown to be effective for acne in studies that included younger patients. Lotion formulations are popular across dermatology and are well-liked by patients, making them a good choice for younger people.
Paper Details　
Original Abstract of the Article :
Acne vulgaris (acne) is a common skin condition in children and adolescents. Efficacy of tretinoin is well documented in studies that included pediatric patients (12-18 years of age). With acne routinely presenting in younger patients, data are needed in this important group. Lotion formulations are...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590503/

データ提供：米国国立医学図書館（NLM）

Tretinoin 0.05% Lotion: A New Approach to Acne Treatment

Acne vulgaris, a common skin condition, is like a stubborn desert shrub, difficult to eradicate. This study focuses on a novel tretinoin 0.05% lotion for the treatment of moderate-to-severe acne vulgaris in preadolescents. The authors explore the efficacy of this lotion in a population often neglected in acne research. The study's findings suggest that this tretinoin 0.05% lotion is a potentially effective treatment option for preadolescents with moderate-to-severe acne. This research is like a new spring of hope in the desert of acne treatment, offering a potentially effective solution for a challenging condition.

A New Spring of Hope in the Desert of Acne

The study's findings provide a glimmer of hope for preadolescents battling moderate-to-severe acne. The authors' observations suggest that the tretinoin 0.05% lotion could be an effective and well-tolerated treatment option for this age group. This discovery is like finding a new oasis in the desert of acne treatment, offering a potential solution for a common and often distressing skin condition.

Navigating the Desert of Acne: A New Route to Clear Skin

This research offers valuable insights into the treatment of acne in preadolescents. The authors' findings provide evidence for the potential efficacy of a novel tretinoin 0.05% lotion, offering a new approach for managing this common skin condition. This research is like a map guiding us towards a clearer future in the desert of acne treatment.

Dr. Camel's Conclusion

This study is like a refreshing breeze in the desert of acne treatment. It provides evidence for the potential efficacy of a novel tretinoin 0.05% lotion, offering a new avenue for managing this common skin condition. This research is a valuable contribution to the fight against acne, potentially leading to improved outcomes for patients of all ages.

Date :
  1. Date Completed 2019-04-01
  2. Date Revised 2021-01-09
Further Info :

Pubmed ID

30656753

DOI: Digital Object Identifier

PMC6590503

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.